TrialBlood2019

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.

Abdulraheem Yacoub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.